Top Markets
#1 Black Phoenix Black Phoenix +852.80%
#2 Nesa Nesa +536.74%
#3 QuantixAI QuantixAI +103.24%
#4 MetaDAO MetaDAO +29.58%
#5 Ontology Gas Ontology Gas +23.90%
#6 Bedrock Bedrock +18.10%
#7 Stacks Stacks +13.77%
#8 peaq peaq +13.54%
#9 Humanity Humanity +13.42%
#10 Moolah Moolah +13.24%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Abivax S.A. Abivax S.A.

Abivax S.A.

ABVX
Classificação em ações #2078
Abivax S.A. is a Paris-based pharmaceutical firm, established in 2013,... Abivax S.A. is a Paris-based pharmaceutical firm, established in 2013, dedicated to identifying and refining treatments for various serious conditions, including inflammatory and infectious diseases, as well as cancer. Its primary drug candidate, ABX464, is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's disease, and COVID-19, and is in Phase IIa trials for rheumatoid arthritis. This compound has also successfully completed a Phase IIa study focused on achieving viral remission in HIV patients. Additionally, the company is advancing ABX 196, an immune-enhancing agent, through Phase 1/2 clinical trials for hepatocellular cancer. Beyond these main programs, Abivax is also engaged in research initiatives targeting Dengue fever, influenza, and the respiratory syncytial virus. The company holds significant licensing agreements with esteemed institutions such as the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie.
Preço da ação
$120.16
Valor de mercado
$10.47B
Variação (1 dia)
3.26%
Variação (1 ano)
58.10%
País
FR
Negociar Abivax S.A. (ABVX)

Categoria

Healthcare
Histórico de preços das ações de Abivax S.A. (ABVX)
Preço de fecho mais alto: $124.85 em 2026-08-01

Preço de fecho mais baixo: $23.10 em 2015-06-01
Histórico de preços das ações da Abivax S.A. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -8.61%
2025 1,503.20%
2024 -26.43%
2023 60.28%
2022 -77.75%
2021 -2.30%
2020 54.91%
2019 56.94%
2018 22.67%
2017 47.19%
2016 -57.07%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.53 41.55%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 51.44%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $151.77 498.70%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH